Sclerodermia

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Sclerodermia.php on line 2
Sclerodermia

LE WE PMID CA

Sclerodermia

2554

Sklerodermie

Arterial hypertension (BASKET)

Autoantibodies Anti PDGF receptor stimulatory

Autoantibodies Anti Topoisomerase I

Blood vessels (Physiology)

Caveolin and caveoles

Fibrosis

Iloprost

Kidney (Failure acute)

Lung (Imaging)

Lysophosphatidate

Nephrogenic systemic fibrosis

Pregnancy (Diseases)

Pulmonary hypertension

Raynaud s syndrome

Scleredema

Sclerodermia

Scleromyxedema

Shulman s syndrome Eosinophilic fasciitis

Skin (Fibrosis)

Skin (Sonography)

SMURF2

Sphingosine1 phosphate

TGF beta

1995 1	ABC of rheumatology. Raynaud's phenomenon, scleroderma, and overlap syndromes. [7711588] BMJ 310(6982): 795-8 (1995)
2006 2	Scleroderma renal crisis: a high index of suspicion speeds diagnosis and life-saving treatment. [16929870] South Med J 99(8): 799-800 (2006)
2007 3	Scleroderma renal crisis: patient characteristics and long-term outcomes. [17601770] QJM 100(8): 485-94 (2007)
2009 4	Scleroderma--pathophysiology. [19059831] Eur J Dermatol 19(1): 14-24 (2009)
1985 5	Hematologic disease in scleroderma syndromes. [2420117] Acta Derm Venereol 65(6): 521-5 (1985)
1976 6	Pathogenesis and staging of scleroderma. [58529] Acta Derm Venereol 56(2): 83-92 (1976)
2002 7	Systemic sclerosis-scleroderma. [12165213] Dermatol Online J 8(1): 3 (2002)
2007 8	[Interstitial lung disease in systemic sclerosis]. [18033190] Rev Mal Respir 24(8): 1035-46 (2007)
2004 9	Low dose warfarin treatment for calcinosis in patients with systemic sclerosis. [15361398] Ann Rheum Dis 63(10): 1341-3 (2004)
1992 10	Remission of scleroderma during chemotherapy for lymphoma. [1417129] Ann Rheum Dis 51(8): 998-1000 (1992)
1991 11	Treatment of systemic sclerosis. [1750801] Ann Rheum Dis 50 Suppl 4(-): 877-86 (1991)
1991 12	The endothelium: its role in scleroderma. [1750799] Ann Rheum Dis 50 Suppl 4(-): 866-71 (1991)
1991 13	Clinical aspects of systemic sclerosis (scleroderma). [1750797] Ann Rheum Dis 50 Suppl 4(-): 854-61 (1991)
2007 14	How does endothelial cell injury start? The role of endothelin in systemic sclerosis. [17767740] Arthritis Res Ther 9 Suppl 2(): S2 (2007)
2007 15	Therapeutic targets in systemic sclerosis. [17767744] Arthritis Res Ther 9 Suppl 2(): S6 (2007)
2007 16	Clinical trials in systemic sclerosis: lessons learned and outcomes. [17767745] Arthritis Res Ther 9 Suppl 2(-): S7 (2007)
2006 17	Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). [16556171] Aliment Pharmacol Ther 23(6): 691-712 (2006)
2007 18	The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. [17330294] Arthritis Rheum 57(2): 203-12 (2007)
2008 19	Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival. [18403656] Chest 134(3): 601-5 (2008)
2007 20	Systemic sclerosis: a prototypic multisystem fibrotic disorder. [17332883] J Clin Invest 117(3): 557-67 (2007)
1988 21	The diagnosis and classification of scleroderma (systemic sclerosis). [3050937] Postgrad Med J 64(748): 121-5 (1988)
1948 22	Pulmonary fibrosis in generalized scleroderma; review of the literature and report of four further cases. [18104278] Thorax 3(4): 241-6 (1948)
1992 23	Scleroderma and the kidney. [1552721] Kidney Int 41(2): 462-77 (1992)
2010 24	The cytokine language of monocytes and macrophages in systemic sclerosis. [21067557] Arthritis Res Ther 12(5): 146 (2010)
2010 25	Vascular alterations upon activation of TGFbeta signaling in fibroblasts--implications for systemic sclerosis. [20602813] Arthritis Res Ther 12(3): 125 (2010)
2010 26	B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis. [20441607] Arthritis Res Ther 12(2): 112 (2010)
2009 27	Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis. [19473554] Arthritis Res Ther 11(2): 220 (2009)
2002 28	Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis. [12124852] Arthritis Rheum 46(7): 1703-13 (2002)
2003 29	Altered negative regulation of transforming growth factor beta signaling in scleroderma: potential involvement of SMURF2 in disease. [12847669] Arthritis Rheum 48(7): 1779-80 (2003)
2003 30	The role of leukotrienes in alveolitis associated with scleroderma. [12794812] Arthritis Rheum 48(6): 1478-80 (2003)
2010 31	Animal models of systemic sclerosis: prospects and limitations. [20617524] Arthritis Rheum 62(10): 2831-44 (2010)
2009 32	Stimulatory autoantibodies to platelet-derived growth factor receptors in systemic sclerosis: what functional autoimmunity could learn from receptor biology. [19333918] Arthritis Rheum 60(4): 907-11 (2009)
2009 33	Health-related quality of life in systemic sclerosis: a systematic review. [19644906] Arthritis Rheum 61(8): 1112-20 (2009)
2008 34	Systemic sclerosis: an update. [18937632] Bull NYU Hosp Jt Dis 66(3): 198-202 (2008)
2010 35	A role for lysophosphatidic acid and sphingosine 1-phosphate in the pathogenesis of systemic sclerosis. [20807477] Discov Med 10(51): 161-7 (2010)
2005 36	Classification of systemic sclerosis. Visions and reality. [15870151] Rheumatology (Oxford) 44(10): 1212-6 (2005)
2009 37	Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis. [19022832] Rheumatology (Oxford) 48(3): 213-21 (2009)
2005 38	Localized scleroderma is an autoimmune disorder. [15561734] Rheumatology (Oxford) 44(3): 274-9 (2005)
2008 39	High-resolution computed tomography and scleroderma lung disease. [18784149] Rheumatology (Oxford) 47 Suppl 5(-): v59-61 (2008)
2008 40	Renal manifestations of systemic sclerosis--clinical features and outcome assessment. [18784147] Rheumatology (Oxford) 47 Suppl 5(-): v54-6 (2008)
2008 41	Outcome measures for heart involvement in systemic sclerosis. [18784146] Rheumatology (Oxford) 47 Suppl 5(-): v51-3 (2008)
2008 42	Pro- and anti-fibrotic effects of TGF-beta in scleroderma. [18784145] Rheumatology (Oxford) 47 Suppl 5(-): v5-7 (2008)
2008 43	Digital ulcers and outcomes assessment in scleroderma. [18784143] Rheumatology (Oxford) 47 Suppl 5(-): v46-7 (2008)
2008 44	Skin involvement in systemic sclerosis. [18784142] Rheumatology (Oxford) 47 Suppl 5(-): v44-5 (2008)
2008 45	Right ventricular function in scleroderma-related pulmonary hypertension. [18784141] Rheumatology (Oxford) 47 Suppl 5(-): v42-3 (2008)
2008 46	Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis. [18784140] Rheumatology (Oxford) 47 Suppl 5(-): v39-41 (2008)
2008 47	Biomarkers in systemic sclerosis. [18784139] Rheumatology (Oxford) 47 Suppl 5(-): v36-8 (2008)
2008 48	Outcome measures in rheumatologic clinical trials and systemic sclerosis. [18784136] Rheumatology (Oxford) 47 Suppl 5(-): v29-30 (2008)
2008 49	Endothelin and scleroderma lung disease. [18784134] Rheumatology (Oxford) 47 Suppl 5(-): v25-6 (2008)
2008 50	Biomarkers of vascular disease in scleroderma. [18784132] Rheumatology (Oxford) 47 Suppl 5(-): v21-2 (2008)
2008 51	Mechanisms of vascular damage in SSc--implications for vascular treatment strategies. [18784130] Rheumatology (Oxford) 47 Suppl 5(-): v18-20 (2008)
2008 52	Macrovascular disease in systemic sclerosis: the tip of an iceberg? [18784129] Rheumatology (Oxford) 47 Suppl 5(-): v16-7 (2008)
2008 53	The microvascular endothelium in scleroderma. [18784128] Rheumatology (Oxford) 47 Suppl 5(-): v14-5 (2008)
2008 54	A path to the future in scleroderma. [18784125] Rheumatology (Oxford) 47 Suppl 5(-): v1 (2008)
2008 55	Pregnancy in systemic sclerosis. [18504278] Rheumatology (Oxford) 47 Suppl 3(-): iii16-8 (2008)
2007 56	Daily cyclophosphamide for scleroderma: are patients with the most to gain underrepresented in this trial? [17984310] Am J Respir Crit Care Med 176(10): 952-3 (2007)
2010 57	Scleroderma in children: emerging management issues. [20657114] Indian J Dermatol Venereol Leprol 76(4): 348-56 (2010)
2008 58	Therapeutic trials for systemic sclerosis: an update. [19052400] Indian J Dermatol Venereol Leprol 74(5): 436-46 (2008)
2010 59	Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis. [21158008] Neth J Med 68(11): 348-53 (2010)
2006 60	Classification in systemic sclerosis. [16652415] J Rheumatol 33(5): 840-1 (2006)
2005 61	The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma). [16142854] J Rheumatol 32(9): 1643-9 (2005)
2011 62	Cardiovascular involvement in patients with systemic sclerosis: insights from electromechanical characteristics of the heart. [21959881] Anadolu Kardiyol Derg 11(7): 643-7 (2011)
2010 63	Biomarkers in systemic sclerosis. [20387310] Biomark Med 4(1): 133-47 (2010)
2005 64	Scleroderma fibroblast survival in Aktion. [15675944] J Invest Dermatol 124(2): viii-xi (2005)
2010 65	Imaging lung disease in systemic sclerosis. [20425026] Curr Rheumatol Rep 12(2): 156-61 (2010)
2010 66	Diagnosis and management of pulmonary hypertension in systemic sclerosis. [20425528] Curr Rheumatol Rep 12(1): 8-18 (2010)
2010 67	Sonographic evaluation of pediatric localized scleroderma: preliminary disease assessment measures. [20423513] Pediatr Rheumatol Online J 8(-): 14 (2010)
2009 68	Localized scleroderma in children: clinical, diagnostic and therapeutic aspects. [19503984] An Bras Dermatol 84(2): 161-72 (2009)
2007 69	Scleroderma renal crisis. [17259685] Indian J Med Sci 61(2): 71-2 (2007)
2008 70	Scleroderma-like fibrosing disorders. [18329541] Rheum Dis Clin North Am 34(1): 199-220; ix (2008)
2008 71	The heart in scleroderma. [18329539] Rheum Dis Clin North Am 34(1): 181-90; viii (2008)
2008 72	Regulation of vascular reactivity in scleroderma: new insights into Raynaud's phenomenon. [18329534] Rheum Dis Clin North Am 34(1): 81-7; vii (2008)
2008 73	Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis. [18949888] Curr Opin Rheumatol 20(6): 713-9 (2008)
2009 74	Therapy for pulmonary arterial hypertension associated with systemic sclerosis. [19667994] Curr Opin Rheumatol 21(6): 642-8 (2009)
2009 75	Innate immunity and inflammation in systemic sclerosis. [19633559] Curr Opin Rheumatol 21(6): 617-22 (2009)
2009 76	Antioxidant effect of Iloprost: current knowledge and therapeutic implications for systemic sclerosis. [19633795] Reumatismo 61(2): 90-7 (2009)
2010 77	Evidence-based management of rapidly progressing systemic sclerosis. [20534372] Best Pract Res Clin Rheumatol 24(3): 387-400 (2010)
2010 78	Pharmacotherapy of systemic sclerosis. [20210685] Expert Opin Pharmacother 11(5): 789-806 (2010)
2010 79	Involvement of mast cells in systemic sclerosis. [20453443] Nihon Rinsho Meneki Gakkai Kaishi 33(2): 81-6 (2010)
2008 80	The roles of chemokines in the development of systemic sclerosis. [18311040] Nihon Rinsho Meneki Gakkai Kaishi 31(1): 23-36 (2008)
2011 81	Vascular involvement in systemic sclerosis (scleroderma). [22096374] J Inflamm Res 4(-): 105-25 (2011)
2010 82	Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy. [20827302] Int J Rheumatol 2010(-): - (2010)
2010 83	Immunotherapy of systemic sclerosis. [21091117] Immunotherapy 2(6): 863-78 (2010)
2011 84	Possible strategies for anti-fibrotic drug intervention in scleroderma. [21484189] J Cell Commun Signal 5(2): 125-9 (2011)
2008 85	The role of B cells in systemic sclerosis. [19707370] Biologics 2(3): 389-95 (2008)
2011 86	Lung involvement in systemic sclerosis. [21195581] Presse Med 40(1 Pt 2): e3-e17 (2011)
2011 87	Coagulation and autoimmunity in scleroderma interstitial lung disease. [21168185] Semin Arthritis Rheum 41(2): 212-22 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Sclerodermia.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Sclerodermia.php on line 92